Loading clinical trials...
Loading clinical trials...
A SINGLE CENTRE, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, 2-WAY CROSS OVER STUDY TO COMPARE SAFETY ASSESSED BY KNEMOMETRY AND URINARY CORTISOL MEASUREMENTS OF CHF1535 50/6 NEXThaler® (FIXED COMBINATION OF BECLOMETHASONE DIPROPIONATE AND FORMOTEROL FUMARATE) AND THE FREE COMBINATION OF LICENSED BECLOMETHASONE DIPROPIONATE AND FORMOTEROL FUMARATE IN ASTHMATIC CHILDREN ALREADY TREATED WITH INHALED CORTICOSTEROIDS
Conditions
Interventions
combination of beclomethasone dipropionate 50µg + formoterol fumarate 6µg
free combination of beclomethasone dipropionate 100µg + Formoterol fumarate 6µg
Locations
1
Denmark
BørneAstmaKlinikken
Copenhagen, Denmark
Start Date
February 1, 2014
Primary Completion Date
November 1, 2015
Completion Date
February 1, 2016
Last Updated
June 18, 2018
NCT07412769
NCT06003569
NCT05667701
NCT05945355
NCT05814510
NCT05332067
Lead Sponsor
Chiesi Farmaceutici S.p.A.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions